Planet 13 Holdings (PLNH) Research & Development (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Research & Development came in at $1.2 million in Q1 2026, down 22.36% year-on-year from $1.5 million in Q1 2025, and up 7.87% on a QoQ basis from $1.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Research & Development (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Research & Development data on file, last reported at $1.2 million in Q1 2026.

  • On a quarterly basis, Research & Development fell 22.36% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $5.1 million, a 15.68% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, down 6.0% from the prior year.
  • Research & Development for Q1 2026 stood at $1.2 million, up from $1.1 million in the prior quarter.
  • Over the last five years, Research & Development for PLNH reached as high as $1.6 million in Q2 2025 and fell as low as $603242.0 in Q1 2022.
  • Historically, Research & Development has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
  • Across the five-year window, Research & Development slumped 52.12% in 2022 and surged 121.43% in 2023, its largest moves.
  • Year by year, Research & Development stood at $1.1 million in 2022, then grew by 25.72% to $1.4 million in 2023, then rose by 5.39% to $1.4 million in 2024, then declined by 21.85% to $1.1 million in 2025, then rose by 7.87% to $1.2 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $1.2 million in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 1.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.11 Mn
Sep 30, 2025 1.17 Mn
Jun 30, 2025 1.63 Mn
Mar 31, 2025 1.55 Mn
Dec 31, 2024 1.42 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 1.29 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 1.33 Mn
Mar 31, 2023 1.34 Mn
Dec 31, 2022 1.08 Mn
Sep 30, 2022 938,269.00
Jun 30, 2022 887,436.00
Mar 31, 2022 603,242.00
Dec 31, 2021 1.81 Mn
Sep 30, 2021 1.96 Mn
Jun 30, 2021 1.54 Mn